Algorithmic folk knowledge: Content creators’ understandings of TikTok’s algorithms
First Monday · 07.04.2026
DOI: 10.5210/fm.v31i4.14362 ↗Kurz gefasst
Fachartikel in der Zeitschrift First Monday, online erschienen am 07.04.2026. Verfasst von Sarah Florini und 4 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0).
Abstract (Originalsprache)
Our research team interviewed 20 TikTok content creators from historically disempowered social groups about their experiences with TikTok’s algorithms. The participants identified consistency in how the platform’s algorithms responded to the visible identities of the creators and to discussion of the social justice-related topics. They also described the relationships they saw between these practices and TikTok’s economic incentives and provided strategies they employed for navigating the platforms’ algorithmic systems. Four key themes emerged in the interviews: 1) Understanding TikTok’s algorithms is largely impossible; 2) Inequitable treatment is driven by relationship between identity and economic incentives; 3) Most aspects of the platform are automated, with humans only involved under limited and specific circumstances; and 4) Factors that impact views, content suppression, and monetization.
Zitieren
APA
Florini, S., Watson, T., O'Neil, E., Grumbach, E., & Gray, C. (2026). Algorithmic folk knowledge: Content creators’ understandings of TikTok’s algorithms. First Monday. https://doi.org/10.5210/fm.v31i4.14362
Vancouver
Florini S, Watson T, O'Neil E, Grumbach E, Gray C. Algorithmic folk knowledge: Content creators’ understandings of TikTok’s algorithms. First Monday. 2026. doi:10.5210/fm.v31i4.14362
BibTeX
@article{Florini2026,
author = {Florini, Sarah and Watson, T.X. and O'Neil, Erica and Grumbach, Elizabeth and Gray, Cecelia},
title = {Algorithmic folk knowledge: Content creators’ understandings of TikTok’s algorithms},
journal = {First Monday},
year = {2026},
doi = {10.5210/fm.v31i4.14362}
}
EUVIMED